Abstract 2799: BAY 1082439, a highly selective and balanced PI3Kα/β inhibitor demonstrated potent activity in tumors with activated PI3Kα and loss-of-function of PTEN
Year: 2012
Type: conference-abstract
Source: Cancer Research
Authors: Ningshu Liu, William J. Scott, Andrea Haegebarth, Ursula Moenning, Robert Fricke, Ulf Boemer, Michael Bruening, Dominik Mumberg, Michael Brands, Karl Ziegelbauer
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2047499539